Michael Hesney

1.1k total citations
25 papers, 896 citations indexed

About

Michael Hesney is a scholar working on Infectious Diseases, Surgery and Pharmacology. According to data from OpenAlex, Michael Hesney has authored 25 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Surgery and 6 papers in Pharmacology. Recurrent topics in Michael Hesney's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), HIV/AIDS drug development and treatment (5 papers) and Nausea and vomiting management (4 papers). Michael Hesney is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), HIV/AIDS drug development and treatment (5 papers) and Nausea and vomiting management (4 papers). Michael Hesney collaborates with scholars based in United States, Germany and Sweden. Michael Hesney's co-authors include Paul Deutsch, Scott A. Waldman, Julie A. Stone, Howard Greenberg, Andrew Sterrett, Gregory A. Winchell, Peter Wickersham, Anup Majumdar, Goutam C. Mistry and Thomas L. Hunt and has published in prestigious journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Michael Hesney

25 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hesney United States 13 380 291 234 152 109 25 896
Goutam C. Mistry United States 15 326 0.9× 346 1.2× 197 0.8× 98 0.6× 133 1.2× 21 939
Gregory A. Winchell United States 15 684 1.8× 224 0.8× 354 1.5× 82 0.5× 16 0.1× 32 1.1k
Olivier Petitjean France 22 246 0.6× 667 2.3× 450 1.9× 75 0.5× 330 3.0× 89 1.6k
Sandrine Lefeuvre France 17 192 0.5× 494 1.7× 362 1.5× 93 0.6× 190 1.7× 36 928
Sou-Yie Chu United States 14 127 0.3× 260 0.9× 260 1.1× 60 0.4× 65 0.6× 24 668
Peter Matzneller Austria 17 160 0.4× 280 1.0× 193 0.8× 77 0.5× 131 1.2× 49 898
J J Schentag United States 16 126 0.3× 541 1.9× 223 1.0× 146 1.0× 205 1.9× 32 1.0k
Robert Sauermann Austria 19 283 0.7× 464 1.6× 255 1.1× 141 0.9× 234 2.1× 43 1.1k
Robert Kulawy United States 21 412 1.1× 515 1.8× 383 1.6× 78 0.5× 402 3.7× 36 1.3k
H Laufen Germany 22 365 1.0× 325 1.1× 470 2.0× 67 0.4× 78 0.7× 76 1.5k

Countries citing papers authored by Michael Hesney

Since Specialization
Citations

This map shows the geographic impact of Michael Hesney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hesney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hesney more than expected).

Fields of papers citing papers by Michael Hesney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hesney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hesney. The network helps show where Michael Hesney may publish in the future.

Co-authorship network of co-authors of Michael Hesney

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hesney. A scholar is included among the top collaborators of Michael Hesney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hesney. Michael Hesney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hruska, Matthew, et al.. (2015). The pharmacokinetics of peginterferon lambda‐1a following single dose administration to subjects with impaired renal function. British Journal of Clinical Pharmacology. 80(3). 515–524. 3 indexed citations
2.
Sims, Karen, Michael Hesney, Megan Wind‐Rotolo, et al.. (2015). P0790 : The effect of renal impairment on multiple-dose pharmacokinetics of the fixed-dose combination of daclatasvir/asunaprevir/beclabuvir. Journal of Hepatology. 62. S628–S628. 5 indexed citations
3.
Tao, Xiaolu, Karen Sims, Michael Hesney, et al.. (2015). P0839 : Evaluation of drug–drug interactions between the fixed-dose combination of daclatasvir/asunaprevir/beclabuvir and methadone or buprenorphine/naloxone. Journal of Hepatology. 62. S652–S652. 1 indexed citations
4.
Garimella, Τushar, Hamza Kandoussi, Michael Hesney, et al.. (2014). 822Effect of Steady State Daclatasvir Plus Asunaprevir on the Single Dose Pharmacokinetics of the P-glycoprotein Substrate Digoxin in Healthy Adult Subjects. Open Forum Infectious Diseases. 1(suppl_1). S235–S235. 4 indexed citations
5.
Mistry, Goutam C., Elizabeth Migoya, Paul Deutsch, et al.. (2007). Single‐ and Multiple‐Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations. The Journal of Clinical Pharmacology. 47(8). 951–961. 49 indexed citations
6.
Mistry, Goutam C., Anup Majumdar, Suzanne K. Swan, et al.. (2006). Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis. The Journal of Clinical Pharmacology. 46(10). 1128–1138. 35 indexed citations
7.
Haas, Sanne Lysbet de, Saco J. de Visser, M. De Smet, et al.. (2006). Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAAα2,3subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. Journal of Psychopharmacology. 21(4). 374–383. 74 indexed citations
8.
Feuring, Martin, Yih Lee, N. Michiels, et al.. (2003). Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects. The Journal of Clinical Pharmacology. 43(8). 912–917. 29 indexed citations
9.
McCrea, Jacqueline B., Anup Majumdar, John M. Busillo, et al.. (2003). Lack of effect of aprepitant on the pharmacokinetics of ondansetron. Clinical Pharmacology & Therapeutics. 73(2). 2 indexed citations
10.
Majumdar, Anup, Donald G. Musson, Steven M. Holland, et al.. (2002). Pharmacokinetics of Ertapenem in Healthy Young Volunteers. Antimicrobial Agents and Chemotherapy. 46(11). 3506–3511. 129 indexed citations
11.
Stone, Julie A., Sherry D. Holland, Peter Wickersham, et al.. (2002). Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men. Antimicrobial Agents and Chemotherapy. 46(3). 739–745. 208 indexed citations
12.
Stone, JA, Peter Wickersham, Paul Deutsch, et al.. (2001). Drug interactions between caspofungin and tacrolimus. 41. 1. 17 indexed citations
13.
Wickersham, Peter, Paul Deutsch, Gregory A. Winchell, et al.. (2001). Effect of hepatic insufficiency on the pharmacokinetics of caspofungin. 41. 1. 12 indexed citations
14.
McCrea, Jacqueline B., et al.. (2000). Enalapril in RAPIDISC (wafer formulation): pharmacokinetic evaluation of a novel, convenient formulation. International Journal of Clinical Pharmacology and Therapeutics. 38(7). 327–332. 4 indexed citations
15.
Yeh, K. C., Paul Deutsch, Michael Hesney, et al.. (1998). Single-Dose Pharmacokinetics of Indinavir and the Effect of Food. Antimicrobial Agents and Chemotherapy. 42(2). 332–338. 100 indexed citations
16.
Bradford, Reagan H., Charles L. Shear, A.N. Chremos, et al.. (1991). Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. The American Journal of Medicine. 91(1). S18–S24. 34 indexed citations
17.
Bradford, Reagan H., Charles L. Shear, Carlos A. Dujovne, et al.. (1990). Expanded clinical evaluation of lovastatin (EXCEL) study: Design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia. The American Journal of Cardiology. 66(8). B44–B55. 26 indexed citations
18.
Corrado, Michael L., Michael Hesney, Kenneth R. Brown, et al.. (1990). Norfloxacin versus Trimethoprim-Sulfamethoxazole in theTreatment of Urinary Tract Infections. European Urology. 17(1). 34–39. 4 indexed citations
19.
Hesney, Michael, et al.. (1988). The tolerability profile of prophylactic norfloxacin in neutropenic patients.. PubMed. 24 Suppl 1. S29–33. 6 indexed citations
20.
Hesney, Michael, et al.. (1985). Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.. PubMed. 7(2). 225–38. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Goutam C. Mistry Breakdown of academic impact, for papers by Gregory A. Winchell Breakdown of academic impact, for papers by Olivier Petitjean Breakdown of academic impact, for papers by Sandrine Lefeuvre Breakdown of academic impact, for papers by Sou-Yie Chu Breakdown of academic impact, for papers by Peter Matzneller Breakdown of academic impact, for papers by J J Schentag Breakdown of academic impact, for papers by Robert Sauermann Breakdown of academic impact, for papers by Robert Kulawy Breakdown of academic impact, for papers by H Laufen
Rankless by CCL
2026